DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Tasquinimod is an investigational drug.
There have been 10 clinical trials for Tasquinimod. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Carcinoma, and Stomach Neoplasms. The leading clinical trial sponsors are Active Biotech AB, Ipsen, and Andrew J. Armstrong, MD.
Recent Clinical Trials for Tasquinimod
|Tasquinimod for the Treatment of Relapsed or Refractory Myeloma||Active Biotech AB||Phase 1|
|Tasquinimod for the Treatment of Relapsed or Refractory Myeloma||University of Pennsylvania||Phase 1|
|A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer||Sidney Kimmel Comprehensive Cancer Center||Phase 1|